Skip to content
Search

Latest Stories

Invatech Health sells its care homes electronic medication administration system to PCS

Health technology pioneer Invatech Health has sold its care homes electronic medication administration record (eMAR) system Atlas to care home management specialists Person Centred Software (PCS).

Following the transition of Atlas to new ownership, Bristol-based Invatech Health will concentrate solely on further growth of Titan, its cutting-edge software for pharmacy management.


Invatech Health CEO Tariq Muhammad, a pharmacist who started working on care homes back in 2002, first conceived the concept of electronic medicines system for care homes in 2006.

Muhammad said he was proud to see his purpose-driven business given an opportunity for further progress. “It’s a bit like being at a child’s graduation,” he said, after the completion of the acquisition which marked the end of a 20 year journey for him with Atlas.

“I set up Atlas to tackle a dire need in the care homes sector for a system which could prevent incorrect dosing, mismanagement of prescriptions and administration errors of important medication.

“For me Atlas has always been about the end user – care homes and their residents. It’s taken a long time to perfect it and, as with any business, there have been bumps along the way.

"Now I’ve taken Atlas as far as I can, so I’m delighted to see it under new ownership, with a company whose values I share and who can allow it to reach greater heights as part of a new ecosystem.

“It’s a clean acquisition, with a complete continuation in staffing and functionality, so it couldn’t have happened any better for all involved.

“My management team and I will oversee the transition over coming months to ensure Atlas is properly bedded in. We can then focus all our efforts into the exciting development of Titan – a similarly cutting-edge product and the equivalent in the rapidly-growing pharmacy sector.

“The potential for Titan is massive. So while I’ve seen one brainchild flying the nest today, there’s another one growing rapidly which needs our full attention.”

PCS, which is based in Guildford in Surrey, confirmed that as part of the acquisition it would retain Atlas’s full team of 15 staff, all of whom work remotely.

Atlas is currently deployed in 700 care homes across the UK, and serviced by a 165-strong network of independent pharmacies, now has the opportunity to be further implemented across PCS’s client base of 3,000 care homes in total.

Jonathan Papworth, co-founder of PCS, said: “I have been impressed with the proven capabilities built into Atlas, alongside the unique level of integration across GPs and pharmacies.

“Atlas is joining our family of social care products to provide best-in-class clinical software for our global customers, from digital care records to medication management and beyond.

“This will provide our joint customers with the opportunity to have full interoperability across our products, as well as the most comprehensive and capable integration with healthcare systems.”

More For You

Walgreens Boots Alliance acquired by Sycamore in deal

Walgreens Boots Alliancehas entered into “a definitive agreement” to be acquired by Sycamore Partners

Gettyimages

Walgreens Boots Alliance acquired by Sycamore in £18.3 billion deal

Walgreens Boots Alliance(WBA) has entered into “a definitive agreement” to be acquired by Sycamore Partners, a private equity firm specializing in retail, consumer and distribution-related investments.

“The total value of the transaction represents up to $23.7 billion (£18.3 billion),” the company announced late last night (6).

Keep ReadingShow less
Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Lawrence Tallon named new MHRA chief executive

Lawrence Tallon

Photo credit: Sciana Network

Lawrence Tallon named new MHRA chief executive

Lawrence Tallon has been appointed as the new chief executive officer of the Medicines and Healthcare products Regulatory Agency (MHRA), effective 1 April 2025.

He will succeed Dame June Raine DBE, who is retiring after leading the agency since 2019.

Keep ReadingShow less